- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03032185
Evaluation of the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Postmenopausal Women
Evaluation of Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Autonomic and Psychophysical Parameters in Postmenopausal Women
Introduction: Menopause is the last menstrual period, it is a natural phenomenon to all women. Postmenopausal, some women may experience unpleasant symptoms such as hot flushes, urogenital pain, headache and pains in the musculoskeletal system. That happens due to the decreased ovarian hormone secretion and changes in the autonomic system. Pain is also caused by a complex autonomic activity. For pain management, a therapeutic electrical stimulation of the peripheral nervous system promotes modulation of nociceptive incentives and release of endogenous opioids. According to reviewed studies, the use of transcutaneous electrical nerve stimulation (TENS), by directly stimulating the central nervous system, has presented results of manipulation of the autonomic system, being observed change in heart rate and cognitive improvement in dementia. Given this possibility, the present study aims to investigate whether the use of Transcutaneous Electrical Nerve Stimulation in low frequency can generate autonomic and psychophysical changes in healthy postmenopausal women.
Objective: To evaluate the effectiveness of Transcutaneous Electrical Nerve Stimulation on autonomic and psychophysical parameters in postmenopausal women.
Methods: randomized, crossover, double-blind. A sample of thirty patients will be selected according to inclusion and exclusion criteria previously established. The autonomic and psychophysical functions will be evaluated by Quantitative Sensory Testing and Conditioned Pain Modulation (pain thresholds to heat and modulation of conditioned pain, respectively), as well as scales to evaluate catastrophism and sleep quality (by scale of Pittsburgh Sleep Quality Index). After application of the scales, the participants will be subject to active Ttranscutaneous Electrical Nerve Stimulation session or sham with a fortnight washout as randomization. All the research subjects will be invited to participate in the study and sign an Informed Consent and Informed (ICI). This study will be registered in the Clinical Trials.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Contact
- Name: Lucélia Cardoso
- Phone Number: 55 51 93646778
- Email: enflucarol@gmail.com
Study Locations
-
-
Rio Grande do Sul
-
Canoas, Rio Grande do Sul, Brazil
- Recruiting
- Andressa de Souza
-
Contact:
- Andressa de Souza, PhD
- Phone Number: +55 51 81975718
- Email: andressa.souza@unilasalle.edu.br
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- To be in the period of post-menopause;
- Do not have chronic diseases or comorbidities in drug treatment;
- Accept to participate in the study and sign the free and informed consent form.
Exclusion Criteria:
- Start continuous medication during the study period;
- Display cognitive problems that make it difficult to understand the questionnaires and proposals;
- History of alcohol or drug abuse in the last 6 months;
- History of neurological disorders;
- History of cardiac arrhythmias;
- History of moderate or severe head injury;
- History of neurosurgery;
- Uncompensated systemic diseases, and chronic inflammatory diseases (diabetes, lupus, rheumatoid arthritis, Sjogren's syndrome, Reiter's syndrome);
- History of uncompensated hypothyroidism;
- History of personal cancer, past or treatment.
- Wish referred to leave the study at any time.
- No attendance to the stages that make up the research.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Active TENS
Active TENS, 10 Hz/200 μs
|
Other Names:
|
Sham Comparator: Not Active TENS
Sham TENS
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Autonomic changes in postmenopausal women's health
Time Frame: 30 days
|
Heart rate's modification tested by R-R interval on electrocardiogram.
|
30 days
|
Psychophysical changes in postmenopausal women´s health
Time Frame: 30 days
|
pain evaluated by Quality Sensitive Test
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Descendent Inibitory System Pain changes in postmenopausal women´s health
Time Frame: 30 days
|
evaluated by conditioned pain modulated test
|
30 days
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 48302915.1.0000.5307
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause
-
Riphah International UniversityCompleted
-
Englewood Hospital and Medical CenterNanohealth, Inc.WithdrawnMenopause SymptomsUnited States
-
Englewood Hospital and Medical CenterNanohealth, Inc.CompletedMenopause SymptomsUnited States
-
University of Colorado, DenverCompletedMenopause | Pre-menopauseUnited States
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedMenopause SymptomsRussian Federation
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasRecruitingMenopause Related ConditionsUnited States
-
Wake Forest University Health SciencesWithdrawnMenopause Related Conditions
-
I.M. Sechenov First Moscow State Medical UniversityCompletedMenopause Related ConditionsRussian Federation
Clinical Trials on Transcutaneous Elevtrical Nerve Stimulation
-
University of L'AquilaCompleted
-
Vrije Universiteit BrusselUnknown
-
Massachusetts General HospitalBrain & Behavior Research FoundationCompletedMajor Depressive DisorderUnited States
-
University Hospital TuebingenUniversität TübingenCompleted
-
Sahlgrenska University Hospital, SwedenRecruitingBorderline Personality DisorderSweden
-
London North West Healthcare NHS TrustUroplasty, IncUnknown
-
Sheffield Teaching Hospitals NHS Foundation TrustNot yet recruitingSubarachnoid Haemorrhage From Cerebral Aneurism RuptureUnited Kingdom
-
University of Colorado, BoulderUniversity of Colorado, Denver; Colorado State UniversityWithdrawn
-
Lawson Health Research InstituteCompleted
-
ADIR AssociationCompletedChronic Obstructive Pulmonary DiseaseFrance